In terms of forecasts by segment, net sales has been reduced by 10 billion yen and operating income has been reduced by 7 billion yen for the Business Technologies Business, while for the Industrial Business net sales and operating income have been increased by 10 billion yen and 6 billion yen, respectively. A 1.5 billion yen upward revision was also made for the operating income of the Healthcare Business. Another way of looking at this is that even if risks associated with the Business Technologies Business for the second half are incorporated and operating income for the Industrial Business (which generated 15.6 billion yen in operating income during the first half) were reduced by half, it would not be necessary to revise the full-year forecast of the entire Group.